OPERATION
BLANKETROL III, Model 233
OPERATION AND TECHNICAL MANUAL
Page 37 of 131
B.
The BLANKETROL III unit is equipped with a circuit breaker in the I/O (on/off) power
switch to protect against current overload.
2-5.
PATIENT PREPARATION AND BEDSIDE CARE
Effective use of the BLANKETROL III System must include proper patient care prior to and while using the
hyper-hypothermia blanket(s).
WARNING
A physician's order is required for setting blanket temperature and use of equipment. At least
every 20 minutes, or as directed by physician, check patient's temperature and skin integrity of
areas in contact with blanket; also, check the BLANKETROL
III’s water temperature. Pediatric
patients, temperature-sensitive patients with vascular disease, surgical patients, diabetics and
patients with Raynaud’s Disease should be checked more frequently.
Notify the physician
promptly of any change in patient status in order to avoid serious injury or death.
The method of temperature control provided by all hyper-hypothermia units presents the
danger of heating or cooling body tissues, particularly the skin, to a point where they are
injured, i.e., burns or frostbite, respectively.
Depending on the extent and severity of a burn,
very serious and even fatal complications may arise.
Do not use the BLANKETROL III System distal to arterial cross clamping.
Thermal injury
may result.
Thermal injury may occur
if heating/cooling therapy is applied to ischemic limbs.
The warming of transdermal medications (patches) can increase drug delivery,
resulting in
possible injury to the patient.
Prevent excessive and/or prolonged tissue pressure and shearing forces, especially over bony
prominences.
Failure to do so may result in tissue injury.
Do not place additional heat sources between the patient and blanket.
Tissue damage may
result.
Means to maintain contact between the patient and the blanket during therapy may be required
and should not block the fluid pathways of the blanket or connecting hose.
Failure to do so
may result in inadequate treatment.
Prep solutions have been reported to injure the skin when allowed to remain between
patients and a water-circulating heating blanket during prolonged procedures. Use of
materials of good thermal conductivity, such as water, gel, and similar substances, with the
BLANKETROL III not switched ON may decrease the temperature of the patient.
The area
between the patient and the blanket should be kept dry to avoid injury to patient.
Proper sanitation procedures must be practiced and hygienic safety must be maintained, to
prevent contamination
.
Contamination can affect patient’s health, i.e. skin irritation/rash
may result.
Use only YSI 400 Series, or equivalent, probes on CSZ equipment (refer to Table (6-8)).
Failure to do this will cause incorrect temperature readings and may result in
inadequate/inappropriate treatment.
Due to static electricity, a 400 Series Probe may not be connected to the BLANKETROL III
unit without first discharging one’s body to the frame of the BLANKETROL III unit or another
grounded object.
Failure to do so may result in damage from electrostatic discharge
(ESD).
All staff that may touch the 400 Series Probe must be familiar with this warning and
basic static electricity or electrostatic discharge (ESD) training.